Právní předpis byl sestaven k datu 01.05.2025.
Zobrazené znění právního předpisu je účinné od 13.12.2014.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015
278/2014 Sb.
278
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 20. listopadu 2014
o xxxxxxxxxx xxxxxxx očkovacích xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2015
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 odst. 1 xxxx. x) xxxxxx x. 258/2000 Sb., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx komise xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2015:
1. Antiqenní složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx očkování
1a) xxxxxxxxxxx xxxxxxxx látka proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx přenosné obrně (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX):
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxx haemagglutinum filamentosum
Pertussis xxxxxxxxx xxxxxxxx xxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx anatoxinum xxx.
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx
Xxxxx poliomyelitidis xxxxxxxxxxx xxxxx 1
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx typus 2
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3
Xxxxxxxxxx Hib: Polyribosylribitoli xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Xxxxxx xxxxxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx typ b ( XXxXXxxXXXXXX)
Xxxxxxxxxxx anatoxinum
Tetani xxxxxxxxxx
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxxxxxxx filamentosum
Virus Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)
xxxxx 1 (Xxxxxxx)
xxxxx 2 (XXX-1)
xxxxx 3 (Xxxxxxx)
Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X
Xxxxxxxxxxx xxxxxxxxxx typu x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx tetani anatoxinum
1b) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx (XXxX):
Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx&xxxx;≥ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 mikrogramů
Pertactinum (69xX) 8 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému kašli (xxxxxxxxxx forma), xxxxxx, xxxxxxx xxxxxxxxx Hemofilem xxxxxxxxxx b (XXxXXxx):
Xxxxxxxxxxx xxxxxxxxxx ........................................... min. 30 xxxxxxxxxxxxx jednotek
Tetani xxxxxxxxxx .................................................... xxx. 40 mezinárodních jednotek
Pertussis xxxxxxxxxx (XX) ...................................... 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) .... 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) ................................................... 8 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx X ....................................... 10 xxxxxxxxxx
xxx xxxxxxxxx xxxxxxxx ............................................ 20-40 xxxxxxxxxx
1x) očkovací xxxxx xxxxx nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x:
1 xxxxx xxxxxxxxxxxxx xxxxxxx obsahuje: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x) očkovací xxxxx xxxxx xxxxxx:
Xxxxxx xxxxxxxxxx ................................................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx 15 let xxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X .......................... 10 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx 16 xxx x výše:
Antigenum tegiminis xxxxxxxxxxx X ........................... 20 mikrogramů
1h) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx a xxxxxxxxx:
Xxxxxxxxxxx xxxxx attenuatum (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50
Xxxxxxxxxxx xxxxx xxxxxxxxxx (XXX 4385) min. 103,7 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50
Xxxxxxxx xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx dávka xxx buněčnou kulturu50
1ch) xxxxxxxx xxxxx proti xxxxxx přenosné xxxxx x inaktivované xxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ........... 40 antigenních D xxxxxxxx*
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 2 (XXX-1) ................ 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx D xxxxxxxx*
* xxxx množství xxxxxxxxxxxxxx xxxxxxxx stanovené xxxxxx xxxxxx imunochemické xxxxxx.
1x) xxxxxxxx xxxxx proti xxxxxxx xxxxxxxxx Streptococcus xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Streptococci xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6B, 7X, 8, 9N, 9X, 10X, 11 X, 12X, 14, 15X, 17X, 18X, 19X, 19F, 20, 22X, 23X, 33F ...... 25 xxxxxxxxxx x xxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx infekcím:
Pneumococcale xxxxxxxxxxxxxxx sérotypus 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9V
Pneumococcale xxxxxxxxxxxxxxx sérotypus 14
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx přenosné obrně (xxxxxxxxxxxx xxxxx):
Xxxxxxxxxxx xxxxxxxxxx ............................... ne méně xxx 2 xxxxxxxxxxx xxxxxxxx
Xxxxxx anatoxinum ........................................ xx xxxx xxx 20 xxxxxxxxxxxxx jednotek
Pertusové xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx................................... 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx ... 8 xxxxxxxxxx
Xxxxxxxxx ...................................................... 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx inactivatum:
typus 1 (xxxx Xxxxxxx) .............................. 40 X jednotek xxxxxxxx
xxxxx 2 (xxxx XXX-1) ................................... 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (kmen Saukett) ................................ 32 X xxxxxxxx xxxxxxxx
XXXX
1xx) očkovací xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxxxxxxx toxoid ....................................... xxxx xxxx rovno 2 xxxxxxxxxxx jednotky (2 Lf)
Tetanický toxoid ....................................... xxxx xxxx xxxxx 20 mezinárodních xxxxxxxx (5 Lf)
Pertusové xxxxxxxx:
Xxxxxxxxx xxxxxx ................................ 2,5 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxxxx ................. 5 xxxxxxxxxx
Xxxxxxx xxxx 2+3 ................................ 5 xxxxxxxxxx
Xxxxxxxxx ............................................. 3 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) ... 40 xxxxxxxxxxx X xxxxxxxx
Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) ... 8 xxxxxxxxxxx X xxxxxxxx
Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) ... 32 antigenních X xxxxxxxx
1x) xxxxxxxx xxxxx proti xxxxxxxxxxx:
Xxxxxxxxxxxxx xxxxx xxxxxxxxxx (XXX) xxxxxxx Xxxxxxx 1331 ... 0,75 xx&xxxx;≥ 2,0 x 106 ≤ 8,0 x 106 XXX (xxxxxx xxxxxxx)
1x) xxxxxxxx látka xxxxx virové xxxxxxxxxx X pro osoby xxxxxxxx xx dialyzačního xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid A (XXX) 50 mikrogramů x 1 xxxxx
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X 20 xxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx vzteklině
Virus xxxxxx xxxxxxxxxxx (kmen Wistar xxxxxx XX/XX 38&xxxx;1503-3X xxxx xxxx xxxxx 2,5 mezinárodních jednotek x 1 xxxxx (0,5 xx)
2x) očkovací xxxxx proti xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X ve xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
X xxxx 2015 s xxxxxxx xx xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx proti xxxxxxxxx xxxxxxx, xxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx látek ve Xxxxxx xxxxxx.
Xxxxxxx:
XXXx. Xxxxxxx, XXX, v. r.
Xxxxxxxxx
Xxxxxx xxxxxxx č. 278/2014 Sb. xxxxx xxxxxxxxx xxxx 13.12.2014.
Xx xxx xxxxxxxx xxxxxx xxxxxxx nebyl měněn xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx aktualizováno, xxxxx se xxxx xxxxxx xxxxxxxxx změna xxxxx uvedeného xxxxxxxx xxxxxxxx.